Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Hietala, J' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 70 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Laakso, A; Bergman, J; Haaparanta, M; Vilkman, H; Solin, O; Syvalahti, E; Hietala, J
      Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia

      SCHIZOPHRENIA RESEARCH
    2. Laakso, MP; Tiihonen, J; Syvalahti, E; Vilkman, H; Laakso, A; Alakare, B; Rakkolainen, V; Salokangas, RKR; Koivisto, E; Hietala, J
      A morphometric MRI study of the hippocampus in first-episode, neuroleptic-naive schizophrenia

      SCHIZOPHRENIA RESEARCH
    3. Laine, TPJ; Ahonen, A; Rasanen, P; Pohjalainen, T; Tiihonen, J; Hietala, J
      The A1 allele of the D-2 dopamine receptor gene is associated with high dopamine transporter density in detoxified alcoholics

      ALCOHOL AND ALCOHOLISM
    4. Hirvonen, J; Nagren, T; Kajander, J; Hietala, J
      Measurement of cortical dopamine D-1 receptor binding with [C-11]SCH 23390: A test-retest analysis

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    5. Kaasinen, V; Nagren, K; Hietala, J; Farde, L; Rinne, JO
      Sex differences in extrastriatal dopamine D-2-like receptors in the human brain

      AMERICAN JOURNAL OF PSYCHIATRY
    6. Laakso, A; Hietala, J
      Detachment and generalized social phobia - Drs. Laakso and Hietala reply

      AMERICAN JOURNAL OF PSYCHIATRY
    7. Hietala, J; Kuoppamaki, M; Majasuo, H; Palvimaki, EP; Laakso, A; Syvalahti, E
      Sertindole is a serotonin 5-HT2c inverse agonist and decreases agonist butnot antagonist binding to 5-HT2c receptors after chronic treatment

      PSYCHOPHARMACOLOGY
    8. Laakso, A; Hietala, J
      PET studies of brain monoamine transporters

      CURRENT PHARMACEUTICAL DESIGN
    9. Oikonen, V; Allonen, T; Nagren, K; Kajander, J; Hietala, J
      Quantification of [carbonyl-C-11]WAY-100635 binding: Considerations on thecerebellum

      NUCLEAR MEDICINE AND BIOLOGY
    10. Syvalahti, EKG; Rakkolainen, V; Aaltonen, J; Lehtinen, V; Hietala, J
      Striatal D-2 dopamine receptor density and psychotic symptoms in schizophrenia: a longitudinal study

      SCHIZOPHRENIA RESEARCH
    11. Vilkman, H; Kajander, J; Nagren, K; Oikonen, V; Syvalahti, E; Hietala, J
      Measurement of extrastriatal D-2-like receptor binding with [C-11]FLB 457 - a test-retest analysis

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    12. Kaasinen, V; Vilkman, H; Hietala, J; Nagren, K; Helenius, H; Olsson, H; Farde, L; Rinne, JO
      Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain

      NEUROBIOLOGY OF AGING
    13. Hallikainen, T; Lachman, H; Saito, T; Volavka, J; Kauhanen, J; Salonen, JT; Ryynanen, OP; Koulu, M; Karvonen, MK; Pohjalainen, T; Syvalahti, E; Hietala, J; Tiihonen, J
      Lack of association between the functional variant of the catechol-o-methyltransferase (COMT) gene and early-onset alcoholism associated with severe antisocial behavior

      AMERICAN JOURNAL OF MEDICAL GENETICS
    14. Kaasinen, V; Nagren, K; Hietala, J; Oikonen, V; Vilkman, H; Farde, L; Halldin, C; Rinne, JO
      Extrastriatal dopamine D2 and D3 receptors in early and advanced Parkinson's disease

      NEUROLOGY
    15. Salokangas, RKR; Vilkman, H; Ilonen, T; Taiminen, T; Bergman, J; Haaparanta, M; Solin, O; Alanen, A; Syvalahti, E; Hietala, J
      High levels of dopamine activity in the basal ganglia of cigarette smokers

      AMERICAN JOURNAL OF PSYCHIATRY
    16. Laakso, A; Vilkman, H; Alakare, B; Haaparanta, M; Bergman, J; Solin, O; Peurasaari, J; Rakkolainen, V; Syvalahti, E; Hietala, J
      Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography

      AMERICAN JOURNAL OF PSYCHIATRY
    17. Laakso, A; Vilkman, H; Kajander, J; Bergman, J; Haaparanta, M; Solin, O; Hietala, J
      Prediction of detached personality in healthy subjects by low dopamine transporter binding

      AMERICAN JOURNAL OF PSYCHIATRY
    18. Hallikainen, T; Saito, T; Lachman, HM; Volavka, J; Pohjalainen, T; Ryynanen, OP; Kauhanen, J; Syvalahti, E; Hietala, J; Tiihonen, J
      Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior

      MOLECULAR PSYCHIATRY
    19. Tiihonen, J; Hallikainen, T; Lachman, H; Saito, T; Volavka, J; Kauhanen, J; Salonen, JT; Ryynanen, OP; Koulu, M; Karvonen, MK; Pohjalainen, T; Syvalahti, E; Hietala, J
      Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism

      MOLECULAR PSYCHIATRY
    20. Pohjalainen, T; Nagren, K; Syvalahti, EKG; Hietala, J
      The dopamine D-2 receptor 5 '-flanking variant, C-141 Ins/Del, is not associated with reduced dopamine D-2 receptor density in vivo

      PHARMACOGENETICS
    21. Hietala, J; Syvalahti, E; Vilkman, H; Vuorio, K; Rakkolainen, V; Bergman, J; Haaparanta, M; Solin, O; Kuoppamaki, M; Eronen, E; Ruotsalainen, U; Salokangas, RKR
      Depressive symptoms and presynaptic dopamine function in neuroleptic-naiveschizophrenia

      SCHIZOPHRENIA RESEARCH
    22. Hietala, J
      Ligand-receptor interactions studied by PET: implications for drug development

      ANNALS OF MEDICINE
    23. Halsas, M; Hietala, J; Veski, P; Jurjenson, H; Marvola, M
      Morning versus evening dosing of ibuprofen using conventional and time-controlled release formulations

      INTERNATIONAL JOURNAL OF PHARMACEUTICS
    24. Hietala, J; Nagren, K; Lehikoinen, P; Ruotsalainen, U; Syvalahti, E
      Measurement of striatal D-2 dopamine receptor density and affinity with [C-11]-raclopride in vivo: A test-retest analysis

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    25. Reinikainen, M; Hietala, J; Walls, M
      Reproductive allocation in Daphnia exposed to toxic cyanobacteria

      JOURNAL OF PLANKTON RESEARCH
    26. Kanerva, H; Vilkman, H; Nagren, K; Kilkku, O; Kuoppamaki, M; Syvalahti, E; Hietala, J
      Brain 5-HT2A receptor occupancy of deramciclane in humans after a single oral administration - a positron emission tomography study

      PSYCHOPHARMACOLOGY
    27. POHJALAINEN T; RINNE JO; NAGREN K; LEHIKOINEN P; ANTTILA K; SYVALAHTI EKG; HIETALA J
      THE A1 ALLELE OF THE HUMAN D-2 DOPAMINE-RECEPTOR GENE PREDICTS LOW D-2 RECEPTOR AVAILABILITY IN HEALTHY-VOLUNTEERS

      Molecular psychiatry
    28. TIIHONEN J; VILKMAN H; RASANEN P; RYYNANEN OP; HAKKO H; BERGMAN J; HAMALAINEN T; LAAKSO A; HAAPARANTASOLIN M; SOLIN O; KUOPPAMAKI M; SYVALAHTI E; HIETALA J
      STRIATAL PRESYNAPTIC DOPAMINE FUNCTION IN TYPE-1 ALCOHOLICS MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY

      Molecular psychiatry
    29. LAAKSO A; BERGMAN J; HAAPARANTA M; VILKMAN H; SOLIN O; HIETALA J
      [F-18] CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - CHARACTERIZATION IN HUMAN-SUBJECTS

      Synapse
    30. LAAKSO A; VILKMAN H; ALAKARE B; HAAPARANTA M; BERGMAN J; SOLIN O; PEURASAARI J; RAKKOLAINEN V; SYVALAHTI EKG; HIETALA J
      ABNORMAL ASYMMETRY OF DOPAMINERGIC NERVE-TERMINALS IN THE CAUDATE-NUCLEUS OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS

      Nordic journal of psychiatry
    31. KAJANDER J; VILKMAN H; SYVALAHTI E; NAGREN K; HIETALA J
      EFFECTS OF REPEATED FLUOXETINE TREATMENT ON STRIATAL D-2 DOPAMINE BINDING IN HUMANS, MEASURED WITH POSITRON-EMISSION-TOMOGRAPHY

      Nordic journal of psychiatry
    32. KARLSSON H; HIETALA J; SAARIJARVI S
      ACUTE PARANOID-HALLUCINATORY PSYCHOSIS AFTER AN OVERDOSE OF FLUOXETINE AND ENALAPRIL - A CASE-REPORT

      Nordic journal of psychiatry
    33. HIETALA J
      IMAGING OF THE DOPAMINERGIC PATHWAYS IN SCHIZOPHRENIA

      Nordic journal of psychiatry
    34. ITO H; HIETALA J; BLOMQVIST G; HALLDIN C; FARDE L
      COMPARISON OF THE TRANSIENT EQUILIBRIUM AND CONTINUOUS-INFUSION METHOD FOR QUANTITATIVE PET ANALYSIS OF [C-11] RACLOPRIDE BINDING

      Journal of cerebral blood flow and metabolism
    35. TIIHONEN J; HALLIKAINEN T; LACHMAN H; VOLAVKA J; HIETALA J; POHJALAINEN T; RYYNANEN OP; KAUHANEN J
      ASSOCIATION BETWEEN THE GENETIC-POLYMORPHISM OF THE OF THE CATECHOL-O-METHYLTRANSFERASE (COMT) AND TYPE-1 ALCOHOLISM

      American journal of medical genetics
    36. REINIKAINEN M; HIETALA J; WALLS M
      ADAPTATIONS AND RESISTANCE OF ZOOPLANKTON TO STRESS - EFFECTS OF GENETIC, ENVIRONMENTAL, AND PHYSIOLOGICAL FACTORS

      Ecotoxicology and environmental safety
    37. POHJALAINEN T; RINNE JO; NAGREN K; SYVALAHTI E; HIETALA J
      SEX-DIFFERENCES IN THE STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN-VIVO

      The American journal of psychiatry
    38. PALVIMAKI EP; MAJASUO H; KUOPPAMAKI M; MANNISTO PT; SYVALAHTI E; HIETALA J
      DERAMCICLANE, A PUTATIVE ANXIOLYTIC DRUG, IS A SEROTONIN 5-HT2C RECEPTOR INVERSE AGONIST BUT FAILS TO INDUCE 5-HT2C RECEPTOR DOWN-REGULATION

      Psychopharmacology
    39. SALONEN I; HIETALA J; LAIHINEN A; LEHIKOINEN P; LEINO L; NAGREN K; RUOTSALAINEN U; OIKONEN V; TUOKKOLA T; NANTO V
      A PET STUDY ON THE ACUTE EFFECT OF ETHANOL ON STRIATAL D2 DOPAMINE-RECEPTORS WITH [C-11] RACLOPRIDE IN HEALTHY-MALES

      Human psychopharmacology
    40. GACSALYI I; SCHMIDT E; GYERTYAN I; VASAR E; LANG A; HAAPALINNA A; FEKETE M; HIETALA J; SYVALAHTI E; TUOMAINEN P; MANNISTO PT
      RECEPTOR-BINDING PROFILE AND ANXIOLYTIC-TYPE ACTIVITY OF DERAMCICLANE(EGIS-3886) IN ANIMAL-MODELS

      Drug development research
    41. HIETALA J; LAURENMAATTA C; WALLS M
      LIFE-HISTORY RESPONSES OF DAPHNIA CLONES TO TOXIC MICROCYSTIS AT DIFFERENT FOOD LEVELS

      Journal of plankton research
    42. KORPELAINEN H; KETOLA M; HIETALA J
      SOMATIC POLYPLOIDY EXAMINED BY FLOW-CYTOMETRY IN DAPHNIA

      Journal of plankton research
    43. LAURENMAATTA C; HIETALA J; WALLS M
      RESPONSES OF DAPHNIA-PULEX POPULATIONS TO TOXIC CYANOBACTERIA

      Freshwater Biology
    44. HIETALA J; LAURENMAATTA C; WALLS M
      SENSITIVITY OF DAPHNIA TO TOXIC CYANOBACTERIA - EFFECTS OF GENOTYPE AND TEMPERATURE

      Freshwater Biology
    45. POHJALAINEN T; CRAVCHIK A; GEJMAN PV; RINNE J; NAGREN K; SYVALAHTI E; HIETALA J
      ANTAGONIST BINDING CHARACTERISTICS OF THE SER(311)-]CYS VARIANT OF HUMAN DOPAMINE D-2 RECEPTOR IN-VIVO AND IN-VITRO

      Biochemical and biophysical research communications
    46. POHJALAINEN T; RINNE JO; NAGREN K; SYVALAHTI EKG; PELTONEN L; HIETALA J
      HUMAN D-2 DOPAMINE-RECEPTOR GENE POLYMORPHISMS AND BINDING CHARACTERISTICS IN-VIVO

      American journal of human genetics
    47. FARDE L; SUHARA T; NYBERG S; KARLSSON P; NAKASHIMA Y; HIETALA J; HALLDIN C
      A PET STUDY OF [C-11]FLB-457 BINDING TO EXTRASTRIATAL D-2-DOPAMINE RECEPTORS IN HEALTHY-SUBJECTS AND ANTIPSYCHOTIC DRUG-TREATED PATIENTS

      Psychopharmacology
    48. HIETALA J; KUOPPAMAKI M; NAGREN K; LEHIKOINEN P; SYVALAHTI E
      EFFECTS OF LORAZEPAM ADMINISTRATION ON STRIATAL DOPAMINE D-2 RECEPTOR-BINDING CHARACTERISTICS IN MAN - A POSITRON EMISSION TOMOGRAPHY STUDY

      Psychopharmacology
    49. LAAKSO A; PALVIMAKI EP; KUOPPAMAKI M; SYVALAHTI E; HIETALA J
      CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS UP-REGULATE 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS

      Neuropsychopharmacology
    50. HAAPARANTA M; BERGMAN J; LAAKSO A; HIETALA J; SOLIN O
      [F-18]CFT ([F-18]WIN-35,428), A RADIOLIGAND TO STUDY THE DOPAMINE TRANSPORTER WITH PET - BIODISTRIBUTION IN RATS

      Synapse
    51. HIETALA J; SYVALAHTI E
      DOPAMINE IN SCHIZOPHRENIA

      Annals of medicine
    52. WONG G; KUOPPAMAKI M; HIETALA J; LUDDENS H; SYVALAHTI E; KORPI ER
      EFFECTS OF CLOZAPINE METABOLITES AND CHRONIC CLOZAPINE TREATMENT ON RAT-BRAIN GABA(A) RECEPTORS

      European journal of pharmacology
    53. TIIHONEN J; KUOPPAMAKI M; NAGREN K; BERGMAN J; ERONEN E; SYVALAHTI E; HIETALA J
      SEROTONERGIC MODULATION OF STRIATAL D-2 DOPAMINE-RECEPTOR BINDING IN HUMANS MEASURED WITH POSITRON EMISSION TOMOGRAPHY

      Psychopharmacology
    54. PALVIMAKI EP; ROTH BL; MAJASUO H; LAAKSO A; KUOPPAMAKI M; SYVALAHTI E; HIETALA J
      INTERACTIONS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS WITH THE SEROTONIN 5-HT2C RECEPTOR

      Psychopharmacology
    55. UHARI M; HIETALA J; TUOKKO H
      RISK OF ACUTE OTITIS-MEDIA IN RELATION TO THE VIRAL ETIOLOGY OF INFECTIONS IN CHILDREN

      Clinical infectious diseases
    56. KUOPPAMAKI M; PALVIMAKI EP; HIETALA J; SYVALAHTI E
      DIFFERENTIAL REGULATION OF RAT 5-HT2A AND 5-HT2C RECEPTORS AFTER CHRONIC TREATMENT WITH CLOZAPINE, CHLORPROMAZINE AND 3 PUTATIVE ATYPICAL ANTIPSYCHOTIC-DRUGS

      Neuropsychopharmacology
    57. RANTALA H; UHARI M; HIETALA J
      FACTORS TRIGGERING THE FIRST FEBRILE SEIZURE

      Acta paediatrica
    58. UHARI M; NIEMELA M; HIETALA J
      PREDICTION OF ACUTE OTITIS-MEDIA WITH SYMPTOMS AND SIGNS

      Acta paediatrica
    59. HIETALA J; REINIKAINEN M; WALLS M
      VARIATION IN LIFE-HISTORY RESPONSES OF DAPHNIA TO TOXIC MICROCYSTIS-AERUGINOSA

      Journal of plankton research
    60. HIETALA J; SYVALAHTI E; VUORIO K; RAKKOLAINEN V; BERGMAN J; HAAPARANTA M; SOLIN O; KUOPPAMAKI M; KIRVELA O; RUOTSALAINEN U; SALOKANGAS RKR
      PRESYNAPTIC DOPAMINE FUNCTION IN STRIATUM OF NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS

      Lancet
    61. HIETALA J; VALTONEN ET; AALTONEN T
      EXPERIMENTAL-INFECTION OF BROWN TROUT, SALMO-TRUTTA L, USING A FINNISH YERSINIA-RUCKERI ISOLATE

      Aquaculture
    62. LAURENMAATTA C; HIETALA J; REINIKAINEN M; WALLS M
      DO MICROCYSTIS-AERUGINOSA TOXINS ACCUMULATE IN THE FOOD-WEB - A LABORATORY STUDY

      Hydrobiologia
    63. KUOPPAMAKI M; SEPPALA T; SYVALAHTI E; HIETALA J
      REGULATION OF SEROTONIN 5-HT2C RECEPTORS IN THE RAT CHOROID-PLEXUS AFTER ACUTE CLOZAPINE TREATMENT

      European journal of pharmacology. Molecular pharmacology section
    64. SYVALAHTI EKG; POHJALAINEN T; KORPI ER; PALVIMAKI EP; OVASKA T; KUOPPAMAKI M; HIETALA J
      DOPAMINE D-2 RECEPTOR GENE-EXPRESSION IN RAT LINES SELECTED FOR DIFFERENCES IN VOLUNTARY ALCOHOL-CONSUMPTION

      Alcoholism, clinical and experimental research
    65. HIETALA J; ROOT A; KNUUTTILA P
      THE SURFACE-ACIDITY OF PURE AND MODIFIED ALUMINAS IN RE AL2O3 METATHESIS CATALYSTS AS STUDIED BY H-1 MAS NMR-SPECTROSCOPY AND ITS IMPORTANCE IN THE ETHENOLYSIS OF 1,5-CYCLOOCTADIENE/

      Journal of catalysis
    66. KUOPPAMAKI M; PALVIMAKI EP; SYVALAHTI E; HIETALA J
      5-HT1C RECEPTOR-MEDIATED PHOSPHOINOSITIDE HYDROLYSIS IN THE RAT CHOROID-PLEXUS AFTER CHRONIC TREATMENT WITH CLOZAPINE

      European journal of pharmacology
    67. HIETALA J; SYVALAHTI E; VUORIO K; NAGREN K; LEHIKOINEN P; RUOTSALAINEN U; RAKKOLAINEN V; LEHTINEN V; WEGELIUS U
      STRIATAL D-2, DOPAMINE-RECEPTOR CHARACTERISTICS IN NEUROLEPTIC-NAIVE SCHIZOPHRENIC-PATIENTS STUDIED WITH POSITRON EMISSION TOMOGRAPHY

      Archives of general psychiatry
    68. HIETALA J; WEST C; SYVALAHTI E; NAGREN K; LEHIKOINEN P; SONNINEN P; RUOTSALAINEN U
      STRIATAL D-2 DOPAMINE-RECEPTOR BINDING CHARACTERISTICS IN-VIVO IN PATIENTS WITH ALCOHOL DEPENDENCE

      Psychopharmacology
    69. PALVIMAKI EP; LAAKSO A; KUOPPAMAKI M; SYVALAHTI E; HIETALA J
      UP-REGULATION OF BETA(1)-ADRENERGIC RECEPTORS IN RAT-BRAIN AFTER CHRONIC CITALOPRAM AND FLUOXETINE TREATMENTS

      Psychopharmacology
    70. KUOPPAMAKI M; SYVALAHTI E; HIETALA J
      CLOZAPINE AND N-DESMETHYLCLOZAPINE ARE POTENT 5-HT(1C) RECEPTOR ANTAGONISTS

      European journal of pharmacology. Molecular pharmacology section


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/12/19 alle ore 01:45:08